AzTrials
AzTrials

Intertrochanteric FracturesNCT03193697

Efficacy and Safety of Cemented and Cementless Prostheses for Unstable Intertrochanteric Fractures in the Elderly

A study testing cemented SPII prosthesis and cementless Wagner prosthesis in people with Intertrochanteric Fractures, run by Harrison International Peace Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This trial explores the application of different hip replacement materials in elderly patients with unstable intertrochanteric fracture, and aims to provide the experience and basis for hip arthroplasty in elderly osteoporosis patients with unstable intertrochanteric fracture. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Intertrochanteric Fractures
What is being tested?
cemented SPII prosthesis and cementless Wagner prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
No sites listed yet
Study dates
1 Jan 2014to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Unstable intertrochanteric fractures identified by imaging and laboratory examination
  • Age: Greater than 65 years old
  • Irrespective of sex
  • Volunteered to participate in this test, and signed informed consent

Who cannot join

  • Replacement contraindications, such as acute myocardial infarction
  • Obvious obstacles in language communication and communication

About this study

Official title: Efficacy and Safety of Cemented and Cementless Prostheses in the Repair of Unstable Intertrochanteric Fractures in the Elderly: a Prospective, Single-center, Non-randomized, Controlled, Clinical Trial With 6-month Follow-up

This trial explores the application of different hip replacement materials in elderly patients with unstable intertrochanteric fracture, and aims to provide the experience and basis for hip arthroplasty in elderly osteoporosis patients with unstable intertrochanteric fracture.

Read the detailed description

Background Intertrochanteric fractures are common types of hip fractures. With the growth of the global aging population, the elderly fracture patients with osteoporosis are increasing. Thus, the difficulty of treating intertrochanteric fractures increases accordingly. Unstable intertrochanteric fractures refer to the fractures from femoral neck base to lesser trochanter level. With the continuous development of China's aging trend, the number of aging population is increasing gradually; the incidence of unstable intertrochanteric fractures is increasing year by year. Clinically, more than 90% of intertrochanteric fractures occur in the elderly over 65 years of age, and the mortality rate is at a high level. Patients with unstable intertrochanteric fractures are older, and body function gradually degrades. The reduction and fixation of this disease are difficult. Therefore, early to find timely and effective treatment is of great significance to patients with unstable intertrochanteric fractures.

Clinically, internal fixation and artificial joint replacement are the primary methods of treating unstable intertrochanteric fractures. The surgical approach of internal fixation is easily affected by the bone quality of the patients. If the patient has different degrees of osteoporosis, it will lead to the failure of the first operation, affecting the prognosis of the patient. Therefore, this kind of operation method is not accepted gradually in clinical practice. The efficacy of joint replacement for treatment of intertrochanteric fracture is remarkable. It can make the patient obtain the immediate stability and reduce complications, so it is very popular with the patients and physicians in the clinic. The most commonly used artificial joint replacement materials in clinic have two types: cemented and cementless prostheses, but the difference in their efficacies and safeties remains poorly understood.

Adverse events To record adverse events, including incision pain, bone cement poisoning, pulmonary infection, mental disorders and acute cerebral infarction.

If severe adverse events occurred, investigators reported details, including the date of occurrence and measures taken to treat the adverse events, to the principle investigator and the institutional review board within 24 hours.

Data collection, management, analysis and open-access Data collection: Records of all cases reported in the trial were complete, clear and true. The case reports were consistent with the patient's original data and the declared data. The collected data were input to the computer in the record room of Harrison International Peace Hospital.

Data management: Data were processed by a special person, and aggregated once a month. During clinical trials, hospital clinic visits were conducted periodically by the clinical ombudsman to ensure that all the contents of the protocols were strictly observed. Simultaneously, raw data were checked to ensure the consistency with the case report form.

Data analysis: Statistical analysis was performed by professional statisticians. The statisticians wrote the research report and submitted it to the researcher for review.

Data open-access: Anonymized trial data will be published at www.figshare.com.

Statistical analysis Statistical analysis was performed using SPSS 19.0 software (IBM, Armonk, NY, USA) and followed the intention-to-treat principle.

Normally distributed measurement data were expressed as means ± standard deviation and minimums and maximums. Non-normally distributed measurement data were expressed as the lower quartile (q1) and median and upper quartiles (q3). Count data were expressed as the percentage. Two-sample t-test was performed for comparison of Harris hip scores, operation time, intraoperative blood loss, postoperative blood transfusion volume, ambulation time and postoperative amount of drainage in both groups. Repeated measures analysis of variance was conducted for intragroup comparison of Harris hip scores at various time points. Pearson X2 test was carried out for comparison of excellent and good rate of Harris hip scores and incidence of adverse reaction in both groups.

The significance level was α = 0.05.

Being tested
cemented SPII prosthesis, cementless Wagner prosthesis
Medical subject headings
Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cemented SPII prosthesisDevice

    Also called control group

    Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty. Forty-four patients in the control group received a cemented SPII prosthesis (Link, Germany).

  • cementless Wagner prosthesisDevice

    Also called trial group

    Old patients with unstable intertrochanteric fractures underwent total hip arthroplasty. Forty-two patients in the trial group received cementless Wagner prosthesis (Zimmer, USA).

Study groups in NCT03193697
Study groupRoleWhat they receive
control groupExperimentalOld patients with unstable intertrochanteric fractures underwent total hip arthroplasty. Forty-four patients in the control group received a cemented SPII prosthesis (Link, Germany).
Receives: Device: cemented SPII prosthesis
trial groupExperimentalOld patients with unstable intertrochanteric fractures underwent total hip arthroplasty. Forty-two patients in the trial group received cementless Wagner prosthesis (Zimmer, USA).
Receives: Device: cementless Wagner prosthesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Harris hip scores

    To assess the recovery of hip function.The number of patients with excellent and good Harris hip scores/total number of patients × 100%. High excellent and good rate indicates good hip function.

    Measured: at postoperative 6 months

Secondary outcomes (1)
  1. X-ray

    To observe morphological changes in the hip.Morphology of the hip was observed in the anteroposterior and lateral images. Heterotopic ossification was classified via the Brooker classification system.

    Measured: Changes from preoperative 6 months to postoperative 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2017
  2. Study start1 Jan 2014
  3. Primary completion1 Jun 2016
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
86 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03193697
Sponsor's protocol ID
HarrisonIPH_01
Status last verified
Feb 2018
First submitted
19 Jun 2017
Last updated
12 Feb 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing cemented SPII prosthesis and cementless Wagner prosthesis in people with Intertrochanteric Fractures, run by Harrison International Peace Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Harris hip scores (time frame: at postoperative 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in